ESC Premium Access

Antiplatelet therapy in high bleeding risk patients with and without oral anticoagulant therapy after coronary stenting

Congress Presentation

About the speaker

Doctor Pieter C Smits

Maasstad Hospital, Rotterdam (Netherlands (The))
5 presentations
0 follower

2 more presentations in this session

SYNTAX II trial: five year follow-up

Speaker: Professor A. Banning (Oxford, GB)


TWILIGHT-HBR: Ticagrelor Monotherapy in High Bleeding Risk Patients

Speaker: Doctor D. Cao (Milan, IT)


Access the full session

Trial Updates in ACS & PCI

Speakers: Doctor P. Smits, Professor A. Banning, Doctor D. Cao

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb